All In MedTech

Device Trial Radar · NCT06101979

A Prospective Study of Fortiva in Hernia Repair

Last checked: Nov 20, 2026Latest source record: Jul 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

120

Planned (sponsor's estimate)

Start

Nov 15, 2023

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Lead sponsor
RTI SurgicalNot on our public-company list
Sponsor type
Industry
First posted
Oct 26, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to evaluate safety and performance of the Fortiva Tissue Matrix. Participants will complete questionnaires to measure outcomes after hernia surgery for two years.

Conditions

  • Ventral Hernia
  • Incisional Hernia
  • Abdominal Wall Reconstruction

Interventions

  • Fortiva Tissue MatrixDevice

    Acellular Dermal Matrix used in hernia surgery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Type of adverse eventsTime frame: 6 weeks, 6 months, 12 months and 24 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • James Paget University Hospital

    Great Yarmouth, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.